Antitumor effect of gene transfection and DNA vacccine of beta-defensins

β-防御素基因转染及DNA疫苗的抗肿瘤作用

基本信息

  • 批准号:
    16591894
  • 负责人:
  • 金额:
    $ 2.08万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2007
  • 项目状态:
    已结题

项目摘要

The present study examined whether increased expression of beta-defensins by the gene transfection affected antitumor of squamous cell carcinoma (SCC), and whether DNA vaccine with beta-defensins affected antitumor of lymphoma. In order to observe the antitumor effect of increased expression of beta-defensins on SCC, adenovirus vectors with beta-defensin were transfected into SCC tissues in nude mice. The diameter of the tumor mass into which the gene was trandected was significantly smaller than that of the controls. The results indicate that beta-defensins themselves may posses a direct antitumor effect against SCC. In order to observe the antitumor effect of DNA vaccine with beta-defensins on lymphoma, the vaccine was injected into A20 lymphoma inBALB/c mice. The survival rate of the vaccination group was significantly longer than that of the control group. The results indicate that DNA vaccine with beta-defensins may be useful in the treatment of lymphoma.
本研究探讨了通过基因转染提高β -防御素的表达是否影响鳞状细胞癌(SCC)的抗肿瘤作用,以及β -防御素DNA疫苗是否影响淋巴瘤的抗肿瘤作用。为了观察β -防御素表达增加对鳞状细胞癌的抗肿瘤作用,我们将β -防御素腺病毒载体转染裸鼠鳞状细胞癌组织。基因转染后的肿瘤肿块直径明显小于对照组。结果表明β -防御素本身可能对SCC具有直接的抗肿瘤作用。为了观察β -防御素DNA疫苗对淋巴瘤的抗肿瘤作用,将该疫苗注射到balb /c小鼠A20淋巴瘤中。接种组的存活率明显长于对照组。结果表明,含有β -防御素的DNA疫苗可用于淋巴瘤的治疗。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single-nucleotide Polymorphism(SNP) in 6-Defensin 2 in a Japanese Population and an Effect of - 1029 SNP on Promoter Activity
日本人群6-防御素2单核苷酸多态性(SNP)及-1029 SNP对启动子活性的影响
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kusano;k.;Abiko;Y.;Nishimura;M.;Arakawa;T.;Takeshima;M.;Fujimoto;A.;Takuma;T.;Kaku;T
  • 通讯作者:
    T
Beta defensin-s engineered epidermis shows highly protective effect fro bacterial infection
Beta 防御素工程化表皮对细菌感染表现出高度保护作用
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sawamura D;Goto M;Shibaki A;Akiyama M;McMillan JR;Abiko Y;Shimizu H.
  • 通讯作者:
    Shimizu H.
Connexin 43 transfection in basaloid squamous cell carcinoma cells.
  • DOI:
    10.3892/or.16.2.285
  • 发表时间:
    2006-08
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    K. Shima;T. Muramatsu;Y. Abiko;Y. Yamaoka;Hodaka Sasaki;M. Shimono
  • 通讯作者:
    K. Shima;T. Muramatsu;Y. Abiko;Y. Yamaoka;Hodaka Sasaki;M. Shimono
Increased expression of beta-defensin-2 and -3 during the development of autoimmune sialoadenitis in MRL/lpr mice. Med Mol Morph
MRL/lpr 小鼠自身免疫性唾液腺炎发展过程中 β-防御素-2 和 -3 的表达增加。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;M.;Kurashige;Y.;Yamazaki;M.;Nishimura;M.;Nakamura;S.;Noro;D.;Takeshima;M.;Arakawa;T.;Takuma;T.;Igarashi;S.;Kaku;T.;Inoue;T.;Abiko;Y
  • 通讯作者:
    Y
口腔扁平苔癬におけるβディフェンシン2の発現と臨床病理学的所見との関連についての検討
口腔扁平苔藓β-防御素2表达与临床病理关系的探讨
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    野口忠秀;神部芳則;草間幹夫;安彦善裕;賀来 亨
  • 通讯作者:
    賀来 亨
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ABIKO Yoshihiro其他文献

Management of Oral Psychosomatic Disorders in Oral Medicine Consultation Clinic in Cooperation with Psychosomatic Medicine and Medical Psychology Clinics
心身医学、医学心理诊所合作口腔医学咨询诊所口腔心身疾病管理
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SAITOH Masato;ABIKO Yoshihiro;KAWAKAMI Tomofumi;IKEDAYasuhiro;NAGAYASU Hiroki;KINOSHITA Kenji;MIYAZAKI Yuka;SHIGA Mitsue;SASAKI Tadashi;SAKANO Yuji
  • 通讯作者:
    SAKANO Yuji

ABIKO Yoshihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ABIKO Yoshihiro', 18)}}的其他基金

Epigenetic alterations of pancreas induced by oral bacterial endotoxin
口腔细菌内毒素诱导胰腺表观遗传改变
  • 批准号:
    20K10187
  • 财政年份:
    2020
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome-wide analysis of epigenetic modification in hippocampus by oral pathogen endotoxin
口腔病原体内毒素对海马表观遗传修饰的全基因组分析
  • 批准号:
    17K11681
  • 财政年份:
    2017
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome-wide analysis of epigenetics in the sialadenitis from Sjogren's syndrome
干燥综合征唾液腺炎的表观遗传学全基因组分析
  • 批准号:
    26462852
  • 财政年份:
    2014
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cognitive behavioral therapy for psychosomatic disorders with pain symptoms in dental settings
针对牙科环境中伴有疼痛症状的心身疾病的认知行为疗法
  • 批准号:
    23659990
  • 财政年份:
    2011
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Susceptibility to bacterial infection by gene transfection of beta defensinsjnto oral epithelial cells
口腔上皮细胞β防御素基因转染对细菌感染的易感性
  • 批准号:
    12671777
  • 财政年份:
    2000
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Antiangiogenic gene therapy with low-dose chemotherapy enhances antitumor activity against oral cancer
低剂量化疗的抗血管生成基因治疗可增强针对口腔癌的抗肿瘤活性
  • 批准号:
    19592322
  • 财政年份:
    2007
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhancing HSV-1 as an Antitumor Gene Therapy Vector
增强 HSV-1 作为抗肿瘤基因治疗载体
  • 批准号:
    7126024
  • 财政年份:
    2004
  • 资助金额:
    $ 2.08万
  • 项目类别:
Enhancing HSV-1 as an Antitumor Gene Therapy Vector
增强 HSV-1 作为抗肿瘤基因治疗载体
  • 批准号:
    7120610
  • 财政年份:
    2004
  • 资助金额:
    $ 2.08万
  • 项目类别:
Enhancing HSV-1 as an Antitumor Gene Therapy Vector
增强 HSV-1 作为抗肿瘤基因治疗载体
  • 批准号:
    6884553
  • 财政年份:
    2004
  • 资助金额:
    $ 2.08万
  • 项目类别:
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY
EGFR反义基因治疗的疗效及抗肿瘤机制
  • 批准号:
    6659251
  • 财政年份:
    2002
  • 资助金额:
    $ 2.08万
  • 项目类别:
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY
EGFR反义基因治疗的疗效及抗肿瘤机制
  • 批准号:
    6493607
  • 财政年份:
    2001
  • 资助金额:
    $ 2.08万
  • 项目类别:
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY
EGFR反义基因治疗的疗效及抗肿瘤机制
  • 批准号:
    6611145
  • 财政年份:
    2001
  • 资助金额:
    $ 2.08万
  • 项目类别:
Basic study for. Cancer Gene Therapy by Antitumor Effects Using Fas-Fas Ligand-Mediated Apoptosis
基础学习。
  • 批准号:
    12671144
  • 财政年份:
    2000
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An experimental study on antitumor immuno-gene therapy using dendritic cells genetically modified to express the tumor antigen gene and cytokine gene
利用基因修饰表达肿瘤抗原基因和细胞因子基因的树突状细胞进行抗肿瘤免疫基因治疗的实验研究
  • 批准号:
    12671170
  • 财政年份:
    2000
  • 资助金额:
    $ 2.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY
EGFR反义基因治疗的疗效及抗肿瘤机制
  • 批准号:
    6480423
  • 财政年份:
    1999
  • 资助金额:
    $ 2.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了